The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Valacyclovir Oral Market Research Report 2025
Synopsis
Valacyclovir is used to treat herpes virus infections, including herpes labialis (also known as cold sores), herpes zoster (also known as shingles), and herpes simplex (also known as genital herpes) in adults. It is also used to treat chickenpox and cold sores in children.
The global Valacyclovir Oral market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Valacyclovir Oral is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Valacyclovir Oral is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Valacyclovir Oral include GSK, Sandoz, Sun Pharmaceutical, Cipla, Mylan, Teva, Zydus Pharmaceuticals, West-Ward Pharmaceuticals and Time Cap Labs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Valacyclovir Oral, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valacyclovir Oral.
Report Scope
The Valacyclovir Oral market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valacyclovir Oral market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valacyclovir Oral manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Sandoz
Sun Pharmaceutical
Cipla
Mylan
Teva
Zydus Pharmaceuticals
West-Ward Pharmaceuticals
Time Cap Labs
Wockhardt
Apotex
Aurobindo Pharma
Jubilant Pharma
Lunan Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Tasly
Segment by Type
500mg Tablet
1000mg Tablet
300mg Tablet
Others
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valacyclovir Oral manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valacyclovir Oral in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Valacyclovir is used to treat herpes virus infections, including herpes labialis (also known as cold sores), herpes zoster (also known as shingles), and herpes simplex (also known as genital herpes) in adults. It is also used to treat chickenpox and cold sores in children.
The global Valacyclovir Oral market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Valacyclovir Oral is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Valacyclovir Oral is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Valacyclovir Oral include GSK, Sandoz, Sun Pharmaceutical, Cipla, Mylan, Teva, Zydus Pharmaceuticals, West-Ward Pharmaceuticals and Time Cap Labs, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Valacyclovir Oral, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Valacyclovir Oral.
Report Scope
The Valacyclovir Oral market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Valacyclovir Oral market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Valacyclovir Oral manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GSK
Sandoz
Sun Pharmaceutical
Cipla
Mylan
Teva
Zydus Pharmaceuticals
West-Ward Pharmaceuticals
Time Cap Labs
Wockhardt
Apotex
Aurobindo Pharma
Jubilant Pharma
Lunan Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Tasly
Segment by Type
500mg Tablet
1000mg Tablet
300mg Tablet
Others
Segment by Application
Hospital
Drug Store
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Valacyclovir Oral manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Valacyclovir Oral in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Valacyclovir Oral Market Overview
1.1 Product Overview and Scope of Valacyclovir Oral
1.2 Valacyclovir Oral Segment by Type
1.2.1 Global Valacyclovir Oral Market Value Comparison by Type (2024-2030)
1.2.2 500mg Tablet
1.2.3 1000mg Tablet
1.2.4 300mg Tablet
1.2.5 Others
1.3 Valacyclovir Oral Segment by Application
1.3.1 Global Valacyclovir Oral Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Valacyclovir Oral Market Size Estimates and Forecasts
1.4.1 Global Valacyclovir Oral Revenue 2019-2030
1.4.2 Global Valacyclovir Oral Sales 2019-2030
1.4.3 Global Valacyclovir Oral Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Valacyclovir Oral Market Competition by Manufacturers
2.1 Global Valacyclovir Oral Sales Market Share by Manufacturers (2019-2024)
2.2 Global Valacyclovir Oral Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Valacyclovir Oral Average Price by Manufacturers (2019-2024)
2.4 Global Valacyclovir Oral Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Valacyclovir Oral, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Valacyclovir Oral, Product Type & Application
2.7 Valacyclovir Oral Market Competitive Situation and Trends
2.7.1 Valacyclovir Oral Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Valacyclovir Oral Players Market Share by Revenue
2.7.3 Global Valacyclovir Oral Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Valacyclovir Oral Retrospective Market Scenario by Region
3.1 Global Valacyclovir Oral Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Valacyclovir Oral Global Valacyclovir Oral Sales by Region: 2019-2030
3.2.1 Global Valacyclovir Oral Sales by Region: 2019-2024
3.2.2 Global Valacyclovir Oral Sales by Region: 2025-2030
3.3 Global Valacyclovir Oral Global Valacyclovir Oral Revenue by Region: 2019-2030
3.3.1 Global Valacyclovir Oral Revenue by Region: 2019-2024
3.3.2 Global Valacyclovir Oral Revenue by Region: 2025-2030
3.4 North America Valacyclovir Oral Market Facts & Figures by Country
3.4.1 North America Valacyclovir Oral Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Valacyclovir Oral Sales by Country (2019-2030)
3.4.3 North America Valacyclovir Oral Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Valacyclovir Oral Market Facts & Figures by Country
3.5.1 Europe Valacyclovir Oral Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Valacyclovir Oral Sales by Country (2019-2030)
3.5.3 Europe Valacyclovir Oral Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Valacyclovir Oral Market Facts & Figures by Country
3.6.1 Asia Pacific Valacyclovir Oral Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Valacyclovir Oral Sales by Country (2019-2030)
3.6.3 Asia Pacific Valacyclovir Oral Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Valacyclovir Oral Market Facts & Figures by Country
3.7.1 Latin America Valacyclovir Oral Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Valacyclovir Oral Sales by Country (2019-2030)
3.7.3 Latin America Valacyclovir Oral Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Valacyclovir Oral Market Facts & Figures by Country
3.8.1 Middle East and Africa Valacyclovir Oral Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Valacyclovir Oral Sales by Country (2019-2030)
3.8.3 Middle East and Africa Valacyclovir Oral Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Valacyclovir Oral Sales by Type (2019-2030)
4.1.1 Global Valacyclovir Oral Sales by Type (2019-2024)
4.1.2 Global Valacyclovir Oral Sales by Type (2025-2030)
4.1.3 Global Valacyclovir Oral Sales Market Share by Type (2019-2030)
4.2 Global Valacyclovir Oral Revenue by Type (2019-2030)
4.2.1 Global Valacyclovir Oral Revenue by Type (2019-2024)
4.2.2 Global Valacyclovir Oral Revenue by Type (2025-2030)
4.2.3 Global Valacyclovir Oral Revenue Market Share by Type (2019-2030)
4.3 Global Valacyclovir Oral Price by Type (2019-2030)
5 Segment by Application
5.1 Global Valacyclovir Oral Sales by Application (2019-2030)
5.1.1 Global Valacyclovir Oral Sales by Application (2019-2024)
5.1.2 Global Valacyclovir Oral Sales by Application (2025-2030)
5.1.3 Global Valacyclovir Oral Sales Market Share by Application (2019-2030)
5.2 Global Valacyclovir Oral Revenue by Application (2019-2030)
5.2.1 Global Valacyclovir Oral Revenue by Application (2019-2024)
5.2.2 Global Valacyclovir Oral Revenue by Application (2025-2030)
5.2.3 Global Valacyclovir Oral Revenue Market Share by Application (2019-2030)
5.3 Global Valacyclovir Oral Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GSK Valacyclovir Oral Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Sandoz
6.2.1 Sandoz Corporation Information
6.2.2 Sandoz Description and Business Overview
6.2.3 Sandoz Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sandoz Valacyclovir Oral Product Portfolio
6.2.5 Sandoz Recent Developments/Updates
6.3 Sun Pharmaceutical
6.3.1 Sun Pharmaceutical Corporation Information
6.3.2 Sun Pharmaceutical Description and Business Overview
6.3.3 Sun Pharmaceutical Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sun Pharmaceutical Valacyclovir Oral Product Portfolio
6.3.5 Sun Pharmaceutical Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla Valacyclovir Oral Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Valacyclovir Oral Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Valacyclovir Oral Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Zydus Pharmaceuticals
6.6.1 Zydus Pharmaceuticals Corporation Information
6.6.2 Zydus Pharmaceuticals Description and Business Overview
6.6.3 Zydus Pharmaceuticals Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zydus Pharmaceuticals Valacyclovir Oral Product Portfolio
6.7.5 Zydus Pharmaceuticals Recent Developments/Updates
6.8 West-Ward Pharmaceuticals
6.8.1 West-Ward Pharmaceuticals Corporation Information
6.8.2 West-Ward Pharmaceuticals Description and Business Overview
6.8.3 West-Ward Pharmaceuticals Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.8.4 West-Ward Pharmaceuticals Valacyclovir Oral Product Portfolio
6.8.5 West-Ward Pharmaceuticals Recent Developments/Updates
6.9 Time Cap Labs
6.9.1 Time Cap Labs Corporation Information
6.9.2 Time Cap Labs Description and Business Overview
6.9.3 Time Cap Labs Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Time Cap Labs Valacyclovir Oral Product Portfolio
6.9.5 Time Cap Labs Recent Developments/Updates
6.10 Wockhardt
6.10.1 Wockhardt Corporation Information
6.10.2 Wockhardt Description and Business Overview
6.10.3 Wockhardt Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Wockhardt Valacyclovir Oral Product Portfolio
6.10.5 Wockhardt Recent Developments/Updates
6.11 Apotex
6.11.1 Apotex Corporation Information
6.11.2 Apotex Valacyclovir Oral Description and Business Overview
6.11.3 Apotex Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Apotex Valacyclovir Oral Product Portfolio
6.11.5 Apotex Recent Developments/Updates
6.12 Aurobindo Pharma
6.12.1 Aurobindo Pharma Corporation Information
6.12.2 Aurobindo Pharma Valacyclovir Oral Description and Business Overview
6.12.3 Aurobindo Pharma Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Aurobindo Pharma Valacyclovir Oral Product Portfolio
6.12.5 Aurobindo Pharma Recent Developments/Updates
6.13 Jubilant Pharma
6.13.1 Jubilant Pharma Corporation Information
6.13.2 Jubilant Pharma Valacyclovir Oral Description and Business Overview
6.13.3 Jubilant Pharma Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jubilant Pharma Valacyclovir Oral Product Portfolio
6.13.5 Jubilant Pharma Recent Developments/Updates
6.14 Lunan Pharmaceutical
6.14.1 Lunan Pharmaceutical Corporation Information
6.14.2 Lunan Pharmaceutical Valacyclovir Oral Description and Business Overview
6.14.3 Lunan Pharmaceutical Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lunan Pharmaceutical Valacyclovir Oral Product Portfolio
6.14.5 Lunan Pharmaceutical Recent Developments/Updates
6.15 Shandong Luoxin Pharmaceutical Group
6.15.1 Shandong Luoxin Pharmaceutical Group Corporation Information
6.15.2 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Description and Business Overview
6.15.3 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Product Portfolio
6.15.5 Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
6.16 Tasly
6.16.1 Tasly Corporation Information
6.16.2 Tasly Valacyclovir Oral Description and Business Overview
6.16.3 Tasly Valacyclovir Oral Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Tasly Valacyclovir Oral Product Portfolio
6.16.5 Tasly Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Valacyclovir Oral Industry Chain Analysis
7.2 Valacyclovir Oral Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Valacyclovir Oral Production Mode & Process
7.4 Valacyclovir Oral Sales and Marketing
7.4.1 Valacyclovir Oral Sales Channels
7.4.2 Valacyclovir Oral Distributors
7.5 Valacyclovir Oral Customers
8 Valacyclovir Oral Market Dynamics
8.1 Valacyclovir Oral Industry Trends
8.2 Valacyclovir Oral Market Drivers
8.3 Valacyclovir Oral Market Challenges
8.4 Valacyclovir Oral Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
